Altrinsic Global Advisors’s Gilead Sciences GILD Stock Holding History

Altrinsic Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-45,000	Closed	-$3.27M	–	60
2021 Q4	$3.27M	Hold	45,000	–	–	0.1%	50
2021 Q3	$3.14M	Sell	45,000 -45,000	-50%	-$3.16M	0.09%	53
2021 Q2	$6.2M	Hold	90,000	–	–	0.19%	48
2021 Q1	$5.82M	Hold	90,000	–	–	0.18%	49
2020 Q4	$5.24M	Buy	90,000 +50,000	+125%	+$3.02M	0.18%	46
2020 Q3	$2.53M	Buy	40,000 +20,000	+100%	+$1.39M	0.1%	50
2020 Q2	$1.54M	Buy	+20,000	New	+$1.53M	0.07%	61
2014 Q2	–	Sell	-94,000	Closed	-$6.66M	–	91
2014 Q1	$6.66M	Hold	94,000	–	–	0.11%	62
2013 Q4	$7.06M	Hold	94,000	–	–	0.12%	50
2013 Q3	$5.91M	Hold	94,000	–	–	0.1%	54
2013 Q2	$4.82M	Buy	+94,000	New	+$4.9M	0.08%	51

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Altrinsic Global Advisors's GILD Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 45,000 shares — an estimated $3.27M sold.

Altrinsic Global Advisors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $7.06M in Q4 2013. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Altrinsic Global Advisors reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Altrinsic Global Advisors sold 45,000 Gilead Sciences shares in Q1 2022, an estimated $3.27M.
Altrinsic Global Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Altrinsic Global Advisors's Gilead Sciences position peaked at $7.06M in Q4 2013.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.